Workplace Wellness Can Help Reduce the Risk for Heart ProblemsVideo
Categories
- Allergy
- Alzheimer's Disease
- Arthritis
- Asthma
- Breast Cancer
- Cardio Health
- Cholesterol
- Cold and Flu
- Colon Cancer
- Diabetes
- Dieting
- Epilepsy
- Hair Loss
- Headache
- Heartburn
- HIV & AIDS
- Kidney Health
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Sclerosis
- Men's Health
- Mental Health
- Nutrition
- Osteoporosis
- Parkinson's Disease
- Prostate Health
- Skin Health
- Sleep Disorders
- Women's Health
- General
Promising Therapy for Prostate Cancer
Posted on 06/22/2009, 14:00
By -- Kevin McKeever
Experimental drug beat back inoperable cancer in two patients, study claims
MONDAY, June 22 (HealthDay News) -- An experimental drug therapy appears to have helped destroy allegedly inoperable prostate cancer in two patients in a clinical trial.
Use of the immunotherapeutic agent MDX-010, or ipilimumab, in combination with standard hormone and radiation treatments helped eliminate the aggressive tumors, which had already spread into the patients' abdominal areas, according to a report from Mayo Clinic researchers that appears in Discovery's Edge, the Mayo Clinic's online research magazine. Both patients are now considered cancer-free.
"The tumors had shrunk dramatically," co-investigator Dr. Michael Blute, a Mayo urologist and surgeon who operated on both patients, said in a Mayo Clinic news release. "I had never seen anything like this before. I had a hard time finding the cancer. At one point, the pathologist [who was working during surgery] asked if we were sending him samples from the same patient."
Ipilimumab is an antibody that appears to greatly magnify the cancer-killing action of androgen ablation, a hormone therapy that helps shrink prostate cancer by eliminating testosterone from the body. Following the additional treatment, the patients showed steady decreases in their prostate-specific antigen (PSA) counts, a test used to detect prostate cancer, and were deemed eligible for surgery. After surgery, one patient underwent additional radiation therapy.
"This is one of the Holy Grails of prostate cancer research," clinical trial leader Dr. Eugene Kwon, a Mayo Clinic urologist, said of the antibody therapy in the same news release.
The team plans more research into how ipilimumab works and how to optimize its use.
More information
The American Cancer Society has more about prostate cancer.
SOURCE: Mayo Clinic, news release, June 19, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
More news in Prostate Health...
BigHealthTree.com Disclaimer
Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.
Some Parents May Hasten Death for Terminally Ill Children
Fitness Academics
Secondhand Smoke Increases Risk for Heart Disease in Kids
Toddlers Don't Learn Vocabulary From TV
Despite Worries, Most Parents Vaccinate Their Kids Anyway
Food Allergies Can Be Treated With the Allergen Foods
Signs of Heart Disease Could Be As Early as 3 in Obese Kids
The Number of Women Having Strokes is Rising
Preventative Mastectomy
Cases of Gestational Diabetes Are On the Rise
Nintendo Wii Could Be Therapy for Stroke Victims
Single Men Have An Increased Risk for Stroke
Fatty Foods Could Lead to Stroke in Older Women
Woman Gives Birth After Ovary Transplant

Comments (0):
Be the first to comment on this article.
Post a comment